MedTrace Logo

"Corticoid-16" in Long Term When Administered Systemically in Patients in Routine Medical Practice

NCT03119454 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2017-04-18

No results posted yet for this study

Summary

Evaluation of pharmacokinetic parameters of diprospan in long term when administered systemically in patients in routine medical practice.

Applied research project.

Design: open-comparative prospective cohort study.

Two groups of subjects:

* patients who are receiving diprospan in standard therapy of their existing disease, or multiple times, but following the introduction of diprospan is planned no earlier than 28 days after the first,
* control group of subjects for the study of pharmacokinetic parameters diprospan and its metabolites.

Objectives of the study: to evaluate the pharmacokinetic parameters of Diprospan in the long term when administered systemically in patients in routine practice.

Conditions

  • Pharmacological Action

Interventions

DRUG

Diprospan

Intramuscular

Sponsors & Collaborators

  • Institute of Biomedical Chemistry, Russia

    collaborator OTHER

  • The League of Clinical Research, Russia

    collaborator OTHER

  • Federal State Budgetary Scientific Institution, Scientific Research Institute of Rheumatology

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-10-31
Primary Completion
2016-11-30
Completion
2016-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03119454 on ClinicalTrials.gov